Prediction of clinically relevant hyperkalemia in patients treated with peptide receptor radionuclide therapy

BACKGROUND: Peptide receptor radionuclide therapy (PRRT) is applied in patients with advanced neuroendocrine tumors. Co-infused amino acids (AA) should prevent nephrotoxicity. The aims of this study were to correlate the incidence of AA-induced hyperkalemia (HK) (≥5.0 mmol/l) and to identify predict...

Descripción completa

Detalles Bibliográficos
Autores principales: Lapa, Constantin, Werner, Rudolf A, Bluemel, Christina, Lueckerath, Katharina, Muegge, Dirk O, Strate, Alexander, Haenscheid, Heribert, Schirbel, Andreas, Allen-Auerbach, Martin S, Bundschuh, Ralph A, Buck, Andreas K, Herrmann, Ken
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4412196/
https://www.ncbi.nlm.nih.gov/pubmed/25977880
http://dx.doi.org/10.1186/s13550-014-0074-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4412196/
https://www.ncbi.nlm.nih.gov/pubmed/25977880
http://dx.doi.org/10.1186/s13550-014-0074-y

Ejemplares similares